OSUR reports plans of developing the in-home Covid-19 self-test
Hello,
What is OSUR?
Orasure Technologies is a Bethlehem, Pennsylvania based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test
News
Stephen Tang -- President and Chief Executive Officer Reports;
I have never been prouder to lead our exceptional company. OraSure has a storied history of rising to the occasion of challenging health circumstances, having developed high-quality diagnostic tests for HIV, HCV and Ebola. As you can imagine, we are doing everything we can to bring our expertise with infectious disease diagnostics in sample collection to the battle against COVID-19. On the testing front, we are developing a pan-SARS coronavirus rapid antigen in-home self-test that uses oral fluid samples and an ELISA-based test for the detection of human anti-SARS-CoV-2 antibodies in oral fluid specimens.
Our molecular solutions business unit is working with laboratories and researchers to demonstrate the effectiveness of our sample collection technologies for coronavirus testing. Later in the call, I will update you on our progress on these items. Turning to the first quarter. I'm pleased to report that OraSure is off to a good start in 2020 with solid financial results.
My thoughts
I have identified a triangle on the monthly chart and have decided to publish this chart from a monthly perspective. It is clear that the past 2 months we have been trending down and will most likely be looking to test for some support. The triangle itself is bearish but triangles are tricky and given the news, if this company develops this in-home Covid-19 self-test and it becomes a hit, well this triangle will become bullish no doubt.
Good Luck, Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
What is OSUR?
Orasure Technologies is a Bethlehem, Pennsylvania based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test
News
Stephen Tang -- President and Chief Executive Officer Reports;
I have never been prouder to lead our exceptional company. OraSure has a storied history of rising to the occasion of challenging health circumstances, having developed high-quality diagnostic tests for HIV, HCV and Ebola. As you can imagine, we are doing everything we can to bring our expertise with infectious disease diagnostics in sample collection to the battle against COVID-19. On the testing front, we are developing a pan-SARS coronavirus rapid antigen in-home self-test that uses oral fluid samples and an ELISA-based test for the detection of human anti-SARS-CoV-2 antibodies in oral fluid specimens.
Our molecular solutions business unit is working with laboratories and researchers to demonstrate the effectiveness of our sample collection technologies for coronavirus testing. Later in the call, I will update you on our progress on these items. Turning to the first quarter. I'm pleased to report that OraSure is off to a good start in 2020 with solid financial results.
My thoughts
I have identified a triangle on the monthly chart and have decided to publish this chart from a monthly perspective. It is clear that the past 2 months we have been trending down and will most likely be looking to test for some support. The triangle itself is bearish but triangles are tricky and given the news, if this company develops this in-home Covid-19 self-test and it becomes a hit, well this triangle will become bullish no doubt.
Good Luck, Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.